Skip to main content

Table 1 Clinical and laboratory data of the study participants (n = 61)

From: Enhanced IFN-γ, but not IL-2, response to Mycobacterium tuberculosis antigens in HIV/latent TB co-infected patients on long-term HAART

Variable No. (%) HIV/latent TB co-infected participants
HAART-naïve
n = 30
HAART-treated
n = 31
Total
n = 61
CD4+ count (cells/μl), Median (IQR) 445 (371–626) 502 (363–564) 477 (367–567)
 201–350 7 (23.3) 4 (12.9) 11 (18.0)
 351–500 10 (33.3) 11 (35.5) 21 (34.4)
 >500 13 (43.3) 16 (51.6) 29 (47.5)
aHistory of Previous BCG Vaccination
 Yes 2 (6.7) 11 (35.5) 13 (21.3)
 No 28 (93.3) 20 (64.5) 48 (78.7)
bRecent infections
 Present 5 (16.7) 1 (3.2) 6 (9.8)
 Absent 25 (83.3) 30 (96.8) 55 (90.2)
  1. aPrior BCG vaccination more than 10 years before the study; b within 3 months before recruitment into study